Osteoporosis

被引:669
作者
Ensrud, Kristine E. [1 ]
Crandall, Carolyn J.
机构
[1] Univ Minnesota, Minneapolis, MN 55455 USA
关键词
BONE-MINERAL DENSITY; VERTEBRAL FRACTURE RISK; TASK-FORCE STRATEGY; OLDER MEN; POSTMENOPAUSAL WOMEN; DIAGNOSTIC-CRITERIA; PREVENT FRACTURES; CLINICAL UTILITY; ALENDRONATE; DISCONTINUATION;
D O I
10.7326/AITC201708010
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
[No abstract available]
引用
收藏
页码:ITC17 / ITC31
页数:15
相关论文
共 70 条
[1]
Performance of the osteoporosis self-assessment screening tool for osteoporosis in American men [J].
Adler, RA ;
Tran, MT ;
Petkov, VI .
MAYO CLINIC PROCEEDINGS, 2003, 78 (06) :723-727
[2]
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research [J].
Adler, Robert A. ;
El-Hajj Fuleihan, Ghada ;
Bauer, Douglas C. ;
Camacho, Pauline M. ;
Clarke, Bart L. ;
Clines, Gregory A. ;
Compston, Juliet E. ;
Drake, Matthew T. ;
Edwards, Beatrice J. ;
Favus, Murray J. ;
Greenspan, Susan L. ;
McKinney, Ross, Jr. ;
Pignolo, Robert J. ;
Sellmeyer, Deborah E. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2016, 31 (01) :16-35
[3]
Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment [J].
Anastasilakis, Athanasios D. ;
Yavropoulou, Maria P. ;
Makras, Polyzois ;
Sakellariou, Grigorios T. ;
Papadopoulou, Fotini ;
Gerou, Spyridon ;
Papapoulos, Socrates E. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2017, 176 (06) :677-683
[4]
[Anonymous], 2004, Bone Health and Osteoporosis: A report of the Surgeon General
[5]
Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports [J].
Aubry-Rozier, B. ;
Gonzalez-Rodriguez, E. ;
Stoll, D. ;
Lamy, O. .
OSTEOPOROSIS INTERNATIONAL, 2016, 27 (05) :1923-1925
[6]
Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy The FLEX Study [J].
Bauer, Douglas C. ;
Schwartz, Ann ;
Palermo, Lisa ;
Cauley, Jane ;
Hochberg, Marc ;
Santora, Art ;
Cummings, Steven R. ;
Black, Dennis M. .
JAMA INTERNAL MEDICINE, 2014, 174 (07) :1126-1134
[7]
Bauer DC, 2013, NEW ENGL J MED, V369, P1537, DOI [10.1056/NEJMcp1210380, 10.1056/NEJMc1314100]
[8]
Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data [J].
Bell, Katy J. L. ;
Hayen, Andrew ;
Macaskill, Petra ;
Irwig, Les ;
Craig, Jonathan C. ;
Ensrud, Kristine ;
Bauer, Douglas C. .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 :1553
[9]
Postmenopausal Osteoporosis [J].
Black, Dennis M. ;
Rosen, Clifford J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (03) :254-262
[10]
The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) [J].
Black, Dennis M. ;
Reid, Ian R. ;
Boonen, Steven ;
Bucci-Rechtweg, Christina ;
Cauley, Jane A. ;
Cosman, Felicia ;
Cummings, Steven R. ;
Hue, Trisha F. ;
Lippuner, Kurt ;
Lakatos, Peter ;
Leung, Ping Chung ;
Man, Zulema ;
Martinez, Ruvie Lou Maria ;
Tan, Monique ;
Ruzycky, Mary Ellen ;
Su, Guoqin ;
Eastell, Richard .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (02) :243-254